New York Times best-selling author Dr. Mike Dow and Ronan Levy, founder of Field Trip, the world's largest provider of psychedelic-assisted psychotherapies, offer ways to integrate ketamine into treatment for depression, anxiety, PTSD, and more.
It's been described as the most important breakthrough in mental health since the introduction of Prozac in 1986. And though once considered taboo, the psychedelic compound, ketamine, is experiencing a spectacular therapeutic comeback.
When combined with psychotherapy, ketamine, which has been described as the being possibly the "most important breakthrough in antidepressant treatment in decades," has the potential to treat depression, anxiety, PTSD, and other debilitating mental illnesses, and change lives.
Unlike antidepressants, which merely mask the pain, psychedelics that heal the brain are the future. Instead of putting Band-Aids on the brain, with Ketamine Assisted-Psychotherapy, you can actually repair the neurological damage caused by stress, anxiety, neglect, and abuse.
In this book, best-selling author Dr. Mike Dow and Field Trip co-founder Ronan Levy provide a broad overview of where KAP came from, how it works, who it works for, and what to expect. More importantly, The Ketamine Breakthrough gives specific protocols for both practitioners and patients to follow in their work with KAP. This book contains hope for those diagnosed with treatment-resistant depression, plagued by trauma and frozen by fears. Ketamine-assisted psychotherapy has also proven effective for people with drug, alcohol, and behavioral addictions, existential depression, grief, and just feeling stuck. People with unresolved resentments, anger, and the everyday anxieties of modern life will also benefit. Ketamine-assisted psychotherapy has been enormously helpful with couples, groups, and veterans, which will be addressed in the book as well.
